Defense

News , articles and essays on Indian Defense

Solar Industries to Deliver First Lot of 40,000 Grenades to Indian Army

CENTRAL Government’s bold decision to open up the ammunition manufacturing sector for private agencies is paying rich dividends as the Indian Army is all set to receive the first consignment of high quality grenades manufactured by Nagpur-based Economic Explosives Limited. It is for the first time in the Indian history a private company is manufacturing ammunition for the Armed Forces.

INS Rajput Decommissioned After 41 Years of Service

“In her glorious service to the nation, the ship has been helmed by 31 commanding officers. The ship, since its commissioning, sailed a distance of over 7,87,194 nautical miles which is equivalent to navigating around the world 36.5 times and 3.8 times the distance from Earth to Moon,” he said in a statement.

Defence Ministry Clears the BRO Tunnel Under Shinkun La in Ladakh

Cutting through the red-tape, the Union defence ministry has decided to ask the Border Roads Organisation (BRO) to build a 4.25-kilometre tunnel under the 5,091-metre-high Shinkun La pass to make an all-weather axis from Manali to Leh via Darcha-Padun-Nimmu alignment to supply Indian Army formations in Ladakh sector. The snow-free axis is expected to be completed by 2024.

Indian Army Engineers Innovate a Solution for Efficient Conversion of Liquid Oxygen to Low Pressure Oxygen Gas for Covid Patients

India’s response to the second COVID wave dictated an exponential demand for oxygen and oxygen cylinders. Since oxygen was transported in liquid form in cryogenic tanks, quick conversion of liquid oxygen to oxygen gas and ensuring availability at the patients’ bed was a critical challenge faced by all hospitals managing COVID patients.

Anti Covid Drug 2-DG Launched by Defence Minister and Health Minister

Minister of Defence, Shri Rajnath Singh and Minister of Health and Family Welfare, Dr. Harsh Vardhan today jointly launched the new COVID drug 2-DG at DRDO Bhawan. The anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), along with Dr Reddy’s Laboratories (DRL), Hyderabad.